Virginia Retirement Systems’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$673K Sell
25,613
-2,500
-9% -$64.9K ﹤0.01% 694
2025
Q3
$635K Sell
28,113
-5,200
-16% -$107K ﹤0.01% 710
2025
Q2
$662K Buy
33,313
+2,400
+8% +$46.8K ﹤0.01% 693
2025
Q1
$522K Buy
+30,913
New +$527K ﹤0.01% 737
2023
Q3
$543K Sell
20,300
-700
-3% -$23.9K 0.01% 671
2023
Q2
$778K Sell
21,000
-800
-4% -$27.9K 0.01% 620
2023
Q1
$681K Hold
21,800
0.01% 656
2022
Q4
$649K Buy
21,800
+3,500
+19% +$125K 0.01% 753
2022
Q3
$698K Buy
+18,300
New +$917K 0.01% 696
2022
Q1
$992K Buy
15,900
+3,900
+33% +$257K 0.01% 645
2021
Q4
$1.21K Sell
12,000
-700
-6% -$61.5K 0.01% 598
2021
Q3
$1.14M Buy
12,700
+1,300
+11% +$118K 0.01% 573
2021
Q2
$1.05M Buy
11,400
+2,000
+21% +$160K 0.01% 634
2021
Q1
$908K Buy
9,400
+2,300
+32% +$237K 0.01% 692
2020
Q4
$370K Buy
+7,100
New +$297K ﹤0.01% 934

Other funds holding FLGT

Virginia Retirement Systems's FLGT Position: Q4 2025 in Review

Virginia Retirement Systems reduced its Fulgent Genetics (FLGT) stake by 8.9% in Q4 2025, selling an estimated $64.9K and leaving 25,613 shares worth $673K. The position accounts for ﹤0.01% of the portfolio, ranked #694.

Virginia Retirement Systems first reported a position in FLGT in Q4 2020 and has held it in 15 quarters since. The position peaked at $1.14M in Q3 2021. 179 funds tracked by Wall St. Rank hold FLGT as of Q4 2025.

  • Virginia Retirement Systems held 25,613 shares of Fulgent Genetics worth $673K as of Q4 2025.
  • Virginia Retirement Systems sold 2,500 Fulgent Genetics shares in Q4 2025, an estimated $64.9K.
  • Fulgent Genetics made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q4 2025, its #694 holding.
  • Virginia Retirement Systems first reported a position in Fulgent Genetics in Q4 2020 and has held it in 15 quarters since.
  • Virginia Retirement Systems's Fulgent Genetics position peaked at $1.14M in Q3 2021.
  • 179 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2025.

Based on Virginia Retirement Systems's 13F filing for Q4 2025, filed 4 Feb 2026.